Clinical Trials Browser

Phase 3 × Not yet recruiting × Rituximab × Clear all

NCT07187960 2025-09-23

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

Phase 3 Not yet recruiting

Lymphoma, Follicular

NCT06573645 2024-08-27

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

Phase 3 Not yet recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse